logologo
QuantliQuantli

CervoMed Inc

CRVO

NASDAQ

Biotechnology

$2.73

USD

-0.20 (-6.83%)

At close: Aug 14, 2026, 4:00 PM EDT

Market Cap $45.36M

Volume 604.8K

Price Target

$18.00$25.00

USD

The 2 analysts offering 1-year price forecasts have a max estimate of $25.00 and a min estimate of $18.00.

Price (USD)
Price (USD)

Past 2Y

1Y Forecast

Price Targets

Average Target

$21.50

-$0.5 vs prior

Implied Upside

+687.5%

-18.3% vs prior

Analyst Covering

2

-2 vs prior period

Consensus

Buy

Unchanged vs prior

Signal Quality

Consensus Freshness

33%

Many ratings are older - consensus may be less current

Analyst Agreement

Low

Targets are widely dispersed - limited agreement on price

Mean vs Median

$0 Gap

Median and average are closely aligned - few outliers skewing the consensus

Analyst Consensus

Strong Sell

Hold

Strong Buy

Buy

2 Buy

0 Hold

0 Sell

Rating Breakdown

Strong Buy

0

Buy

2

Hold

0

Sell

0

Strong Sell

0

2 analysts · last 3 months

Covering Analysts

Unlock each analyst's profile, success rate + price targets

Free shows the consensus and each analyst's current rating.

AnalystFirmRatingActionDateSuccess RatePrice TargetImplied Upside

Raghuram Selvaraju

HC Wainwright & Co.

Buy

Reiterated

4 days ago

Plus
Plus
Plus

Sumant Kulkarni

Canaccord Genuity

Buy

Maintained

6 days ago

Plus
Plus
Plus

Frequently Asked Questions

Similar Stocks

NXTC

NextCure Inc

$8.21

-0.8%

TVGN

Tevogen Bio Holdings Inc

$6.87

+4.6%

ELUT

Elutia Inc

$0.9400

+9.4%

BYSI

Beyondspring Inc

$0.8400

-15.8%

ALGS

Aligos Therapeutics Inc

$6.89

+1.8%

MCRB

Seres Therapeutics Inc

$4.54

+1.3%

LTRN

Lantern Pharma Inc

$2.65

+0.8%